Clinical study on biapenem in respiratory infections

Abstract

A clinical evaluation of biapenem (BIPM), a new carbapenem antibiotic, was performed 13 patients (5 with pneumonia, 4 with lower respiratory tract infection, 3 with empyema and 1 with lung abscess).
The clinical responses in 13 cases were excellent in 1, good in 7 and poor in 3, an efficacy rate of 72.7%.
Side effects were noted in 3 cases (eruption, anorexia, vomiting), Abnormal laboratory finding was observed in 1 case (eosinophilia).